COVID-19 Ä¡·áÁ¦ »ç¿ë±ÝÁö : À̺ÎÇÁ·ÎÆæ(Ibuprofen), ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦(NSAIDs)
'ÀÇÇÐ Àú³Î ¶õ¼Â(The Lancet Respiratory Medicine) À̺ÎÇÁ·ÎÆæ(Ibuprofen) ±ÝÁö' °¡¼³
ÀÇÇÐ Àú³Î ¶õ¼Â(The Lancet Respiratory Medicine)Àº À̺ÎÇÁ·ÎÆæÀ» Æ÷ÇÔÇÑ ÀϺΠ¾àÇ°ÀÌ °íÇ÷¾ÐÀ̳ª ´ç´¢º´À» ¾Î´Â COVID-19 ȯÀÚ¿¡°Ô À§ÇèÇÒ ¼ö ÀÖ´Ù´Â °¡¼³À» ¹ßÇ¥Çß´Ù. À̺ÎÇÁ·ÎÆæÀº ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁøÅëÁ¦·Î, ÁøÅëÁ¦³ª ÇØ¿Á¦·Îµµ ¾²ÀδÙ. ‘¶õ¼Â È£Èí±âÀÇÇÐ(Lancet Respiratory Medicine)’¿¡¼ ¸¶ÀÌŬ ·Î½º(Michael Roth) ¹ÙÁ©ÀÇ´ë ±³¼ö´Â À̺ÎÇÁ·ÎÆæÀ» º¹¿ëÇϸé COVID-19ÀÇ ÁÖ¿ä ħÅõ °æ·ÎÀΠǥÀû ´Ü¹éÁú ACE2°¡ ¼¼Æ÷¿¡ °ú´Ù ¹ßÇöµÅ COVID-19ÀÇ ÁßÁõµµ ¶Ç´Â °¨¿° À§ÇèÀ» ³ôÀÏ ¼ö ÀÖÀ½À» ¹àÇû´Ù.
(Source: The Lancet April, 2020 Issue4, Vol 8, page e-21)
¼¼°èº¸°Ç±â±¸(WHO) ¿ª½Ã COVID-19 °¨¿°½Ã¿¡ Áõ»ó¿Ïȸ¦ À§ÇØ ¼Ò¿°Á¦ À̺ÎÇÁ·ÎÆæ(ibuprofen)À» ó¹æÀ» ÇÏÁö ¸»µµ·Ï ±Ç°íÇß´Ù. ¹Ì±¹ FDA ¿ª½Ã The Lancet medical journalÀÇ ¿¬±¸°á°ú¸¦ ¹ÙÅÁÀ¸·Î COVID-19 ȯÀÚ¿¡°Ô À̺ÎÇÁ·ÎÆæ(Ibuprofen) °°Àº ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦(Non-steroidal anti-inflammatory drugs, NSAIDs) »ç¿ëÀÌ COVID-19 Áõ»óÀ» ´õ ¾ÇȽÃų ¼ö ÀÖÀ½À» º¸°íÇÏ¿´´Ù.
ÇÁ¶û½º º¸°Çº¹ÁöºÎ´Â À̺ÎÇÁ·ÎÆæ(Ibuprofen)°°Àº ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦(NSAIDs) »ç¿ëÀ» °æ°íÇÏ°í À̺ÎÇÁ·ÎÆæÀ̳ª, ÄÚ¸£Æ¼¼Õ(½ºÅ×·ÎÀ̵å) µî ÁøÅë¼Ò¿°Á¦°¡ COVID-19¸¦ ¾ÇȽÃų ¼ö ÀÖÀ½À¸·Î ŸÀÌ·¹³î µî ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀ¸·Î ´ëüÇÏ¿© »ç¿ëÇÒ °ÍÀ» ±Ç°íÇß´Ù. [¿ø¹® ¹Ù·Î°¡±â]
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ Á¦°ø